AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 794.00 Change Price %
High 802.00 1 Day 11.90 1.51
Low 788.30 1 Week 61.95 8.41
Close 798.55 1 Month 7.10 0.90
Volume 1541064 1 Year 42.15 5.57
52 Week High 891.50
52 Week Low 582.00
AUROPHARMA Important Levels
Resistance 2 811.25
Resistance 1 806.02
Pivot 796.28
Support 1 791.08
Support 2 785.85
NSE INDIA Most Active Stocks
WELSPUNIND 46.65 -3.72%
UNITECH 5.20 0.00%
JINDALSTEL 87.80 2.93%
RCOM 53.75 -0.19%
SBIN 252.25 1.28%
ICICIBANK 256.25 2.30%
DLF 162.15 2.43%
INDIACEM 151.40 5.69%
AXISBANK 591.15 0.34%
CROMPGREAV 81.85 1.80%
More..
NSE INDIA Top Gainers Stocks
SRGINFOTEC 0.30 20.00%
NIRVIKARA 61.60 19.96%
ZICOM 47.90 19.90%
GAL 83.10 18.21%
GAL 83.10 18.21%
GAL 83.10 18.21%
VISAKAIND 187.55 18.03%
MVL 0.35 16.67%
MVL 0.35 16.67%
RAJOIL 1.75 16.67%
More..
NSE INDIA Top Losers Stocks
VGUARD 188.90 -89.39%
KSERASERA 0.15 -25.00%
MENONBE 85.20 -14.24%
GEMINI 2.00 -13.04%
REISIXTEN 0.40 -11.11%
SAMTEL 0.50 -9.09%
CINEVISTA 7.65 -8.93%
XLENERGY 2.75 -8.33%
MBLINFRA 96.70 -8.21%
VALECHAENG 27.80 -7.49%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 30th Aug 2016 AUROPHARMA Share Price closed @ 798.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 773.97 & Strong Buy for SHORT-TERM with Stoploss of 760.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for August
1st Target up-side 830.12
2nd Target up-side 857.22
3rd Target up-side 884.32
1st Target down-side 752.78
2nd Target down-side 725.68
3rd Target down-side 698.58
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 59.84 Sideways
MFI (14) MFI is 56.47 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is 15.86 Range Bound
PSAR Stoploss For Long Buy 743.00
10 Day Avg Volume Traded -40.48 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.